Annual Operating Profit
-$37.06 M
+$13.12 M+26.15%
December 31, 2023
Summary
- As of February 8, 2025, SNSE annual operating income is -$37.06 million, with the most recent change of +$13.12 million (+26.15%) on December 31, 2023.
- During the last 3 years, SNSE annual operating profit has fallen by -$18.35 million (-98.07%).
- SNSE annual operating profit is now -198.06% below its all-time high of -$12.44 million, reached on December 31, 2019.
Performance
SNSE Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$7.82 M
-$36.00 K-0.46%
September 30, 2024
Summary
- As of February 8, 2025, SNSE quarterly operating income is -$7.82 million, with the most recent change of -$36.00 thousand (-0.46%) on September 30, 2024.
- Over the past year, SNSE quarterly operating profit has increased by +$319.00 thousand (+3.92%).
- SNSE quarterly operating profit is now -129.62% below its all-time high of -$3.41 million, reached on December 31, 2019.
Performance
SNSE Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$32.48 M
-$86.00 K-0.27%
September 30, 2024
Summary
- As of February 8, 2025, SNSE TTM operating income is -$32.48 million, with the most recent change of -$86.00 thousand (-0.27%) on September 30, 2024.
- Over the past year, SNSE TTM operating profit has increased by +$4.58 million (+12.36%).
- SNSE TTM operating profit is now -853.39% below its all-time high of -$3.41 million, reached on December 31, 2019.
Performance
SNSE TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
SNSE Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +26.1% | +3.9% | +12.4% |
| 3 y3 years | -98.1% | +40.0% | +35.3% |
| 5 y5 years | -190.9% | +40.0% | +35.3% |
SNSE Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +26.1% | -1.1% | +43.9% | -0.3% | +35.3% |
| 5 y | 5-year | -198.1% | +26.1% | -129.6% | +43.9% | -853.4% | +35.3% |
| alltime | all time | -198.1% | +26.1% | -129.6% | +43.9% | -853.4% | +35.3% |
Sensei Biotherapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$7.82 M(+0.5%) | -$32.48 M(+0.3%) |
| Jun 2024 | - | -$7.79 M(-10.8%) | -$32.40 M(-6.9%) |
| Mar 2024 | - | -$8.73 M(+7.2%) | -$34.79 M(-6.1%) |
| Dec 2023 | -$37.06 M(-26.1%) | -$8.14 M(+5.2%) | -$37.06 M(-11.7%) |
| Sep 2023 | - | -$7.74 M(-24.0%) | -$41.97 M(-12.9%) |
| Jun 2023 | - | -$10.18 M(-7.5%) | -$48.17 M(-1.1%) |
| Mar 2023 | - | -$11.01 M(-15.6%) | -$48.71 M(-2.9%) |
| Dec 2022 | -$50.19 M | -$13.05 M(-6.4%) | -$50.19 M(+7.8%) |
| Sep 2022 | - | -$13.94 M(+30.1%) | -$46.55 M(+8.4%) |
| Jun 2022 | - | -$10.71 M(-14.2%) | -$42.93 M(+2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$12.49 M(+32.7%) | -$42.00 M(+12.1%) |
| Dec 2021 | -$37.48 M(+100.3%) | -$9.41 M(-8.8%) | -$37.48 M(+13.1%) |
| Sep 2021 | - | -$10.32 M(+5.4%) | -$33.15 M(+17.6%) |
| Jun 2021 | - | -$9.78 M(+22.8%) | -$28.19 M(+24.9%) |
| Mar 2021 | - | -$7.97 M(+57.0%) | -$22.58 M(+20.7%) |
| Dec 2020 | -$18.71 M(+50.5%) | -$5.08 M(-5.4%) | -$18.71 M(+9.8%) |
| Sep 2020 | - | -$5.36 M(+28.7%) | -$17.04 M(+45.9%) |
| Jun 2020 | - | -$4.17 M(+1.6%) | -$11.68 M(+55.5%) |
| Mar 2020 | - | -$4.10 M(+20.4%) | -$7.51 M(+120.4%) |
| Dec 2019 | -$12.44 M(-2.4%) | -$3.41 M | -$3.41 M |
| Dec 2018 | -$12.74 M | - | - |
FAQ
- What is Sensei Biotherapeutics annual operating income?
- What is the all time high annual operating profit for Sensei Biotherapeutics?
- What is Sensei Biotherapeutics annual operating profit year-on-year change?
- What is Sensei Biotherapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Sensei Biotherapeutics?
- What is Sensei Biotherapeutics quarterly operating profit year-on-year change?
- What is Sensei Biotherapeutics TTM operating income?
- What is the all time high TTM operating profit for Sensei Biotherapeutics?
- What is Sensei Biotherapeutics TTM operating profit year-on-year change?
What is Sensei Biotherapeutics annual operating income?
The current annual operating profit of SNSE is -$37.06 M
What is the all time high annual operating profit for Sensei Biotherapeutics?
Sensei Biotherapeutics all-time high annual operating income is -$12.44 M
What is Sensei Biotherapeutics annual operating profit year-on-year change?
Over the past year, SNSE annual operating income has changed by +$13.12 M (+26.15%)
What is Sensei Biotherapeutics quarterly operating income?
The current quarterly operating profit of SNSE is -$7.82 M
What is the all time high quarterly operating profit for Sensei Biotherapeutics?
Sensei Biotherapeutics all-time high quarterly operating income is -$3.41 M
What is Sensei Biotherapeutics quarterly operating profit year-on-year change?
Over the past year, SNSE quarterly operating income has changed by +$319.00 K (+3.92%)
What is Sensei Biotherapeutics TTM operating income?
The current TTM operating profit of SNSE is -$32.48 M
What is the all time high TTM operating profit for Sensei Biotherapeutics?
Sensei Biotherapeutics all-time high TTM operating income is -$3.41 M
What is Sensei Biotherapeutics TTM operating profit year-on-year change?
Over the past year, SNSE TTM operating income has changed by +$4.58 M (+12.36%)